green8,
Hi, I love this part of your post!
"TK was excited in relation to the USA testing with the fact all our “buckets” are now full / “overflowing” which will enable parallel submission to FDA for all the illnesses mentioned in the recent announcement, not just pneumonia."
That part is exciting and as a result, will bring forward some other milestones for FDA approval, re those other illnesses like croup, COPD, etc.
MTW
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Presentation at ASX Spotlight Investor Conference
Ann: ResApp Presentation at ASX Spotlight Investor Conference, page-45
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online